From Start to Finish: How Agilent Can Support Better Decisions in IVT mRNA-Based Biopharmaceutical Analysis

From Start to Finish: How Agilent Can Support Better Decisions in IVT mRNA-Based Biopharmaceutical Analysis

We will discuss how automated electrophoresis and LC/MS systems solutions from Agilent provide reliable insights for IVT mRNA workflows at many steps.
From Start to Finish: How Agilent Can Support Better Decisions in IVT mRNA-Based Biopharmaceutical Analysis
All About USP 467 Residual Solvent: Regulatory and Application Updates

All About USP 467 Residual Solvent: Regulatory and Application Updates

Recent changes in USP 467, latest trends & applications in residual solvent analysis along with analytical workflow in order to get accurate & reproducible results.
All About USP 467 Residual Solvent: Regulatory and Application Updates
Characterization and sequence mapping of large RNA and mRNA therapeutics using HRAM

Characterization and sequence mapping of large RNA and mRNA therapeutics using HRAM

The presentation showcases the innovative partial T1 digest strategy developed at the University of Sheffield for sequencing mRNA therapeutics.
Characterization and sequence mapping of large RNA and mRNA therapeutics using HRAM
Agilent 8700 LDIR Workflows

Agilent 8700 LDIR Workflows

The two main worklflows of the LDIR will be discussed and demonstrated.
Agilent 8700 LDIR Workflows
Method Validation

Method Validation

We´ll discuss practical guidance around accuracy, precision, limit of quantitation and limit of detection and next we´ll walk you through an Empower CDS tool.
Method Validation
Mastering the Quantitative Bioanalysis of Large Peptides and Proteins: A Case Study of GLP-1 Receptor Agonist Semaglutide in Plasma

Mastering the Quantitative Bioanalysis of Large Peptides and Proteins: A Case Study of GLP-1 Receptor Agonist Semaglutide in Plasma

We present new data demonstrating a comprehensive and streamlined approach to optimized LC-MS/MS quantification of peptides, addressing the common challenges.
Mastering the Quantitative Bioanalysis of Large Peptides and Proteins: A Case Study of GLP-1 Receptor Agonist Semaglutide in Plasma
The merger of automated LC fractionation & in-depth characterization

The merger of automated LC fractionation & in-depth characterization

Dr. Kristensen discusses how the shift from traditional data handling methods to cloud solutions has revolutionized their workflow, enabling access to vast amounts of data from anywhere.
The merger of automated LC fractionation & in-depth characterization
Unlocking precision: nitrosamine and NDSRI analysis

Unlocking precision: nitrosamine and NDSRI analysis

We invite you to join our webinar on nitrosamine and NDSRIs, specifically examining their analysis and implications in the pharmaceutical industry.
Unlocking precision: nitrosamine and NDSRI analysis
Meet Aunty, the Queen of high-throughput protein stability characterization

Meet Aunty, the Queen of high-throughput protein stability characterization

Join this webinar to see how to set up and run an Aunty experiment.
Meet Aunty, the Queen of high-throughput protein stability characterization
Incorporating ultrashort-chain compounds into the comprehensive analysis of PFAS

Incorporating ultrashort-chain compounds into the comprehensive analysis of PFAS

Join Dr. Shun-Hsin Liang, as he explores the simultaneous analysis of C1 to C14 PFCA and PFSA, along with other PFAS types, using two alternative chromatographic approaches.
Incorporating ultrashort-chain compounds into the comprehensive analysis of PFAS